Director/PDMR Shareholding

RNS Number : 8308M
Smith & Nephew Plc
13 May 2020
 

 

SMITH & NEPHEW PLC

 

13 May 2020

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc SPON ADR American Depositary Shares

 

 

Identification code

ISIN: US83175M2052

Nature of the transaction

PDMR is a participant of the Company's Employee Stock Purchase Plan, which purchased American Depository Shares through the Company's Dividend Re-Investment Plan following the 2019 final dividend payment on 6 May 2020.

Date of Transaction

2020 - 05 - 07

Place of Transaction

New York Stock Exchange

 

Name

Director / PDMR

Price ($)

Volume

Aggregated information

Total Share Holding following the transaction *

Total Share Holding as a % of the Company's ISC following the transaction *

Bradley Cannon

PDMR

40.5546

16.68663

N/A Single Transaction

64,081.78031 (including 1,514.48130 in ADS')

0.00724%

Catheryn O'Rourke

PDMR

40.5546

57.33651

N/A Single Transaction

61,334.86758 (including 5,201.91068 in ADS')

0.00693%

 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

 

 

Vickie Reuben  

Deputy Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477410

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFSRERIVLII
UK 100

Latest directors dealings